Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) Equity Average (2016 - 2025)

Historic Equity Average for AtriCure (ATRC) over the last 15 years, with Q3 2025 value amounting to $470.5 million.

  • AtriCure's Equity Average rose 149.84% to $470.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $470.5 million, marking a year-over-year increase of 149.84%. This contributed to the annual value of $463.6 million for FY2024, which is 45.67% up from last year.
  • AtriCure's Equity Average amounted to $470.5 million in Q3 2025, which was up 149.84% from $459.6 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Equity Average registered a high of $486.1 million during Q4 2021, and its lowest value of $388.2 million during Q2 2021.
  • Its 5-year average for Equity Average is $454.2 million, with a median of $459.6 million in 2025.
  • In the last 5 years, AtriCure's Equity Average soared by 6929.04% in 2021 and then crashed by 670.25% in 2022.
  • AtriCure's Equity Average (Quarter) stood at $486.1 million in 2021, then fell by 6.7% to $453.5 million in 2022, then increased by 2.42% to $464.5 million in 2023, then dropped by 0.32% to $463.0 million in 2024, then rose by 1.62% to $470.5 million in 2025.
  • Its Equity Average was $470.5 million in Q3 2025, compared to $459.6 million in Q2 2025 and $457.8 million in Q1 2025.